Baseline Serum Biomarkers Do Not Predict Dupilumab Treatment Response in AdultsWith Moderate-to-Severe Atopic Dermatitis

被引：0

作者：

Weidinger, Stephan ^{[1
]}

Beck, Lisa A. ^{[2
]}

de Bruin-Weller, Marjolein S. ^{[3
]}

Thyssen, Jacob P. ^{[4
]}

Kabashima, Kenji ^{[5
]}

Guttman-Yassky, Emma ^{[6
]}

Akdis, Cezmi A. ^{[7
]}

Chen, Zhen ^{[8
]}

Levit, Noah A. ^{[8
]}

Bastian, Mike ^{[9
]}

机构：

[1] Univ Hosp Schleswig Holstein, Kiel, Germany

[2] Univ Rochester, Med Ctr, Rochester, NY USA

[3] Univ Med Ctr Utrecht, Utrecht, Netherlands

[4] Univ Copenhagen, Bispebjerg Hosp, Copenhagen, Denmark

[5] Kyoto Univ, Grad Sch Med, Kyoto, Japan

[6] Icahn Sch Med Mt Sinai, Med Ctr, New York, NY USA

[7] Univ Zurich, Swiss Inst Allergy & Asthma Res, Zurich, Switzerland

[8] Regeneron Pharmaceut Inc, Tarrytown, NY USA

[9] Sanofi, Frankfurt, Germany

来源：

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2023年 / 21卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P157

引用

页码：101 / 101

页数：1

共 50 条

[1] Baseline serum biomarkers do not predict dupilumab treatment response in adults with moderate-to-severe atopic dermatitis
Weidinger, Stephan
Beck, Lisa A.
de Bruin-Weller, Marjolein S.
Thyssen, Jacob P.
Kabashima, Kenji
Guttman-Yassky, Emma
Akdis, Cezmi A.
Chen, Zhen
Levit, Noah A.
Bastian, Mike
BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
[2] Dupilumab in the treatment of moderate-to-severe atopic dermatitis
Kraft, Magdalena
Worm, Margitta
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (04) : 301 - 310
[3] Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
Beck, Lisa A.
Thaci, Diamant
Hamilton, Jennifer D.
Graham, Neil M.
Bieber, Thomas
Rocklin, Ross
Ming, Jeffrey E.
Ren, Haobo
Kao, Richard
Simpson, Eric
Ardeleanu, Marius
Weinstein, Steven P.
Pirozzi, Gianluca
Guttman-Yassky, Emma
Suarez-Farinas, Mayte
Hager, Melissa D.
Stahl, Neil
Yancopoulos, George D.
Radin, Allen R.
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (02): : 130 - 139
[4] Dupilumab: A Review in Moderate-to-Severe Atopic Dermatitis
Frampton, James E.
Blair, Hannah A.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2018, 19 (04) : 617 - 624
[5] Dupilumab: A Review in Moderate-to-Severe Atopic Dermatitis
James E. Frampton
Hannah A. Blair
American Journal of Clinical Dermatology, 2018, 19 : 617 - 624
[6] Psoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in children
Parker, Jennifer J.
Sugarman, Jeffrey L.
Silverberg, Nanette B.
Gonzalez, Mercedes Elena
Ramien, Michele L.
Teng, Joyce M. C.
Paller, Amy S.
PEDIATRIC DERMATOLOGY, 2021, 38 (06) : 1500 - 1505
[7] Rapid response to dupilumab treatment in children with moderate-to-severe atopic dermatitis: A case series
Votto, Martina
Delle Cave, Francesco
De Filippo, Maria
Marseglia, Alessia
Marseglia, Gian Luigi
Brazzelli, Valeria
Licari, Amelia
PEDIATRIC ALLERGY AND IMMUNOLOGY, 2022, 33 : 31 - 33
[8] Dupilumab treatment in children with moderate-to-severe atopic dermatitis increases levels of bone mineralization biomarkers
Irvine, A. D.
Paller, A.
Horowitz, J. E.
Farrell, A.
Hatsell, S.
Ehmann, P.
Rodriguez Marco, A.
Tian, T.
Cyr, S. L.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S110 - S110
[9] Dupilumab treatment in children with moderate-to-severe atopic dermatitis increases levels of bone mineralization biomarkers
Irvine, Alan D.
Paller, Amy S.
Horowitz, Julie E.
Farrell, Annamaria
Hatsell, Sarah
Ehmann, Peter
McDonald, Robert
Marco, Ainara Rodriguez
Tian, Tingting
Cyr, Sonya L.
BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
[10] An Observational Study of Early Treatment Response and Predictors of Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis
Deng, Sisi
Wang, Huan
Fu, Jiong
Zhai, Zhifang
Chen, Qiquan
Song, Zhiqiang
DERMATOLOGIC THERAPY, 2024, 2024

← 1 2 3 4 5 →